Conditioning Regimens in Patients with β-Thalassemia Who Underwent Hematopoietic Stem Cell Transplantation: A Scoping Review

Pretransplant myeloid and immune suppression, reduced toxicity conditioning with posttransplant cyclophosphamide: Initial outcomes of novel approach for matched unrelated donor hematopoietic stem cell transplant for hemoglobinopathies

(2021) Gaurav Kharya et al.   PEDIATRIC BLOOD & CANCER

β-Thalassemias

(2021) Ali T. Taher et al.   NEW ENGLAND JOURNAL OF MEDICINE

HSCT remains the only cure for patients with transfusion-dependent thalassemia until gene therapy strategies are proven to be safe

(2021) Christina Oikonomopoulou et al.   BONE MARROW TRANSPLANTATION

Current status of beta‐thalassemia and its treatment strategies

(2021) Shaukat Ali et al.   Molecular Genetics & Genomic Medicine

Two decades of experience in a combined adult/pediatric allogeneic hematopoietic stem cell transplantation center in Algiers, Algeria

(2020) Malek Benakli et al.   ANNALS OF HEMATOLOGY

A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia

(2020) M. Domenica Cappellini et al.   NEW ENGLAND JOURNAL OF MEDICINE

Changing patterns in the epidemiology of β‐thalassemia

(2020) Antonis Kattamis et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation

(2019) Séverine Coquerelle et al.   HUMAN GENE THERAPY

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

(2018) Alexis A. Thompson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome

(2017) Hala Gabr et al.   TRANSPLANT IMMUNOLOGY

Allogeneic Stem Cell Transplantation in Congenital Hemoglobinopathies Using a Tailored Busulfan-Based Conditioning Regimen: Single-Center Experience

(2016) Irina Zaidman et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hematopoietic stem cell transplantation for homozygous β-thalassemia and β-thalassemia/hemoglobin E patients from haploidentical donors

(2016) U Anurathapan et al.   BONE MARROW TRANSPLANTATION

Hemopoietic stem cell transplantation in thalassemia: a report from the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Registry, 2000–2010

(2016) D Baronciani et al.   BONE MARROW TRANSPLANTATION

Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies

(2015) Allison A. King et al.   AMERICAN JOURNAL OF HEMATOLOGY

Outcomes of Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplantation by Using a Standard Myeloablative versus a Novel Reduced-Toxicity Conditioning Regimen According to a New Risk Stratification

(2014) Usanarat Anurathapan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-haploidentical stem cell transplantation after removal of   + T and B cells in children with nonmalignant disorders

(2014) A. Bertaina et al.   BLOOD

TLI-based reduced-intensity conditioning hematopoietic SCT for children and adolescents with high-risk nonmalignant disorders

(2014) A A Hussein et al.   BONE MARROW TRANSPLANTATION

Unrelated Umbilical Cord Blood Transplant for Children with β-Thalassemia Major

(2014) Sandip A. Shah et al.   INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION

A Novel Reduced-Intensity Conditioning Regimen for Unrelated Umbilical Cord Blood Transplantation in Children with Nonmalignant Diseases

(2013) Suhag H. Parikh et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Bone marrow transplantation for thalassemia from alternative related donors: improved outcomes with a new approach

(2013) J. Gaziev et al.   BLOOD

Risk adopted allogeneic hematopoietic stem cell transplantation using a reduced intensity regimen for children with thalassemia major

(2013) Ayad Ahmed Hussein et al.   PEDIATRIC BLOOD & CANCER

Improved Clinical Outcomes of High Risk β Thalassemia Major Patients Undergoing a HLA Matched Related Allogeneic Stem Cell Transplant with a Treosulfan Based Conditioning Regimen and Peripheral Blood Stem Cell Grafts

(2013) Vikram Mathews et al.   PLoS One

Treosulfan-Thiotepa-Fludarabine–Based Conditioning Regimen for Allogeneic Transplantation in Patients with Thalassemia Major: A Single-Center Experience from North India

(2012) Dharma Choudhary et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A novel conditioning regimen improves outcomes in  -thalassemia major patients using unrelated donor peripheral blood stem cell transplantation

(2012) C. Li et al.   BLOOD

Allogeneic hematopoietic stem cell transplantation in thalassemia major: results of a reduced-toxicity conditioning regimen based on the use of treosulfan

(2012) M. E. Bernardo et al.   BLOOD

Umbilical Cord Blood Transplantation for Children with Thalassemia and Sickle Cell Disease

(2011) Annalisa Ruggeri et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Unrelated cord blood transplantation for thalassaemia: a single-institution experience of 35 patients

(2011) T-H Jaing et al.   BONE MARROW TRANSPLANTATION

HLA-matched sibling stem cell transplantation in children with β-thalassemia with anti-thymocyte globulin as part of the preparative regimen: the Greek experience

(2011) E Goussetis et al.   BONE MARROW TRANSPLANTATION

Interactions between killer immunoglobulin-like receptors and their human leucocyte antigen Class I ligands influence the outcome of unrelated haematopoietic stem cell transplantation for thalassaemia: a novel predictive algorithm

(2011) Roberto Littera et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pathogenesis and management of iron toxicity in thalassemia

(2010) Chaim Hershko   Annals of the New York Academy of Sciences

Prospective Assessment of Health-Related Quality of Life in Pediatric Patients with Beta-Thalassemia following Hematopoietic Stem Cell Transplantation

(2010) Giovanni Caocci et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Unpredictability of Intravenous Busulfan Pharmacokinetics in Children Undergoing Hematopoietic Stem Cell Transplantation for Advanced Beta Thalassemia: Limited Toxicity with a Dose-Adjustment Policy

(2009) Robert Chiesa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Long‐term results of survival in patients with thalassemia major treated with bone marrow transplantation

(2008) Paolo Di Bartolomeo et al.   AMERICAN JOURNAL OF HEMATOLOGY

Peripheral Blood versus Bone Marrow as a Source of Hematopoietic Stem Cells for Allogeneic Transplantation in Children With Class I and II Beta Thalassemia Major

(2008) Ardeshir Ghavamzadeh et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hematopoietic stem cell transplantation in Oman

(2008) D Dennison et al.   BONE MARROW TRANSPLANTATION

Hematopoietic stem cell transplantation in Lebanon: first comprehensive report

(2008) A Bazarbachi et al.   BONE MARROW TRANSPLANTATION

Allogeneic hematopoietic SCT performed in non-HEPA filter rooms: initial experience from a single center in India

(2008) R Kumar et al.   BONE MARROW TRANSPLANTATION

Treosulfan-based conditioning regimen for allogeneic haematopoietic stem cell transplantation in patients with thalassaemia major

(2008) Maria Ester Bernardo et al.   BRITISH JOURNAL OF HAEMATOLOGY

Advances in the allogeneic transplantation for thalassemia

(2007) Guido Lucarelli et al.   BLOOD REVIEWS